Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy
- 1 January 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 32 (1), 67-71
- https://doi.org/10.1016/j.jcrs.2005.06.051
Abstract
To assess the presence of mitomycin-C (MMC) in hen aqueous humor after photorefractive keratectomy (PRK). Instituto Universitario de Oftalmobiología Aplicada, Faculty of Medicine, University of Valladolid, and Department of Analytical Chemistry, Faculty of Sciences, University of Valladolid, Valladolid, Spain. Mitomycin-C 0.02% was applied topically for 2 minutes to a right hen's eye after PRK (Group A) and to the left eye with intact epithelium (Group B). At different time points (10, 30, 60, 360, and 720 minutes), aqueous humor was extracted and high-performance liquid chromatography was performed to detect and quantify MMC levels. The mean maximum drug concentration of MMC measured in the aqueous humor was 187.250 microg/L +/- 4.349 (SD) in Group A and 93.000 +/- 4.899 microg/L in Group B, both detected 10 minutes after topical application. Statistically significant differences were found between Groups A and B at 10, 30, and 60 minutes, with decreasing MMC levels in both groups but a higher concentration in Group A. After 360 minutes, MMC levels were undetectable in Group B and after 720 minutes in Group A. Mitomycin-C was detectable in the aqueous humor of the hen eye after topical application in PRK-treated eyes and in eyes with intact epithelium. The presence of MMC is of concern as it may lead to ocular toxicity in the long term.Keywords
This publication has 33 references indexed in Scilit:
- A Comparative Evaluation of the Efficacy of Intraoperative Mitomycin C Use After the Excision of Cobblestone-Like Papillae in Severe Atopic and Vernal KeratoconjunctivitisCornea, 2004
- Photorefractive Keratectomy with Mitomycin C for the Management of a LASIK Flap Complication Following a Penetrating KeratoplastyCornea, 2004
- Mitomycin C Alters Corneal Stromal Wound Healing and Corneal Haze in Rabbits After Argon-Fluoride Excimer Laser Photorefractive KeratectomyJournal of Ocular Pharmacology and Therapeutics, 2004
- Correlation between the Early Morphological Appearance of Filtering Blebs and Outcome of Trabeculectomy with Mitomycin CJournal of Glaucoma, 2003
- Silicone nasolacrimal intubation with mitomycin-C: a prospective, randomized, double-masked studyOphthalmology, 2003
- Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomyJournal of Cataract & Refractive Surgery, 2002
- Mitomycin C Reduces Corneal Light Scattering After Excimer KeratectomyCornea, 2001
- A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitisOphthalmology, 2000
- Topical Mitomycin-C for subepithelial fibrosis after refractive corneal surgeryOphthalmology, 2000
- Modulation of Corneal Wound Healing After Excimer Laser Keratomileusis Using Topical Mitomycin C and SteroidsAmerican Journal of Ophthalmology, 1991